1.1 Death |
12 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
1.1.1 Death at day 30 |
12 |
4826 |
Risk Ratio (M‐H, Random, 95% CI) |
0.97 [0.87, 1.09] |
1.1.2 Death after 30 days |
7 |
4534 |
Risk Ratio (M‐H, Random, 95% CI) |
0.99 [0.92, 1.07] |
1.2 Death or non‐recovery kidney function at day 90 |
6 |
4011 |
Risk Ratio (M‐H, Random, 95% CI) |
0.91 [0.74, 1.11] |
1.3 Recovery of kidney function |
10 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
1.3.1 Patients free from KRT according to ITT analysis (all patients) |
10 |
4717 |
Risk Ratio (M‐H, Random, 95% CI) |
1.07 [0.94, 1.22] |
1.3.2 Survivors free from KRT according to ITT after 30 days |
10 |
2510 |
Risk Ratio (M‐H, Random, 95% CI) |
1.02 [0.97, 1.07] |
1.4 Adverse events |
7 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
1.4.1 Any adverse event |
5 |
3983 |
Risk Ratio (M‐H, Random, 95% CI) |
1.23 [0.90, 1.68] |
1.4.2 Hypophosphataemia |
1 |
2927 |
Risk Ratio (M‐H, Random, 95% CI) |
1.80 [1.33, 2.44] |
1.4.3 Hypotension |
5 |
3864 |
Risk Ratio (M‐H, Random, 95% CI) |
1.54 [1.29, 1.85] |
1.4.4 Cardiac‐rhythm disorder |
6 |
4483 |
Risk Ratio (M‐H, Random, 95% CI) |
1.35 [1.04, 1.75] |
1.4.5 Infection |
5 |
4252 |
Risk Ratio (M‐H, Random, 95% CI) |
1.33 [1.00, 1.77] |
1.4.6 Bleeding |
6 |
4358 |
Risk Ratio (M‐H, Random, 95% CI) |
0.91 [0.71, 1.18] |
1.4.7 Thrombocytopenia |
1 |
106 |
Risk Ratio (M‐H, Random, 95% CI) |
1.03 [0.20, 5.35] |
1.5 Length of stay |
7 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
1.5.1 Length of stay in ICU |
5 |
4240 |
Mean Difference (IV, Random, 95% CI) |
‐1.01 [‐1.60, ‐0.42] |
1.5.2 Length of stay in hospital |
7 |
4589 |
Mean Difference (IV, Random, 95% CI) |
‐2.45 [‐4.75, ‐0.14] |